Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist 2018;11:1249-60.
Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39(3):309-17.
The National Antimicrobial Resistant Surveillance Thailand. Antibiogram 2018 (Accessed July 28, 2019, at http://narst. dmsc.moph.go.th/).
Isler B, Doi Y, Bonomo RA, et al. New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections. Antimicrob Agents Chemother 2018;63(1).pii: e01110-18.
Puttilerpong C, Chawanasit W, Laohawaleesan W, et al. Antimicrobial Use in Hospital-Acquired Pneumonia with Multidrug-Resistant Acinetobacter baumannii at King Chulalongkorn Memorial Hospital. Thai Pharm Health Sci J 2011;6(6):32-8.
Koomanachai P, Tiengrim S, Kiratisin P, et al. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Int J Infect Dis 2007;11(5):402-6.
Park SY, Choo JW, Kwon SH, et al. Risk Factors for Mortality in Patients with Acinetobacter baumannii Bacteremia. Infect Chemother 2013;45(3):325-30.
Kim YJ, Kim SI, Hong KW, et al. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy. J Korean Med Sci 2012;27(5):471-5.
Santimaleeworagun W, Sumret W, Limsubjaroen K, et al. Clinical Outcomes and Risk Factors Affecting 30-day Mortality and Treatment Failure of Patients Infected with Carbapenem- Resistant Acinetobacter baumanii in a General Hospital. Silpakorn University Science and Technology J 2014;8(1):9.
Jamulitrat S, Thongpiyapoom S, Suwalak N. An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis. J Med Assoc Thai 2007;90(10):2181-91.
Santimaleeworagun W, Wongpoowarak P, Chayakul P, et al. Clinical outcomes of patients infected with carbapenemresistant Acinetobacter baumannii treated with single or combination antibiotic therapy. J Med Assoc Thai 2011;94(7):863-70.
Brotfain E, Borer A, Koyfman L, et al. Multidrug Resistance Acinetobacter Bacteremia Secondary to Ventilator-Associated Pneumonia: Risk Factors and Outcome. J Intensive Care Med 2017;32(9):528-34.
